Pragmatic research and outcomes in asthma and COPD

References

• Centers for Disease Control and PreventionNational Center for Health StatisticsAsthma Available from: http://www.cdc.gov/vitalsigns/Asthma/Accessed October 5, 2011
   Google Scholar
• QaseemAWiltTJWeinbergerSEDiagnosis and management of stable chronic obstructive pulmonary disease: a clinical practice guideline update from the American College of Physicians, American College of Chest Physicians, American Thoracic Society, and European Respiratory SocietyAnn Intern Med2011155317919121810710
   PubMed Web of Science ®Google Scholar
• National Heart Lung and Blood InstituteCOPD for Health Care Professionals Available from: http://www.nhlbi.gov/health/public/lung/copd/index.htmAccessed October 5, 2011
   Google Scholar
• SullivanPWGhushchyanVHSlejkoJFBelozeroffVGlobeDRLinSLThe burden of adult asthma in the United States: evidence from the Medical Expenditure Panel SurveyJ Allergy Clin Immunol2011127236336921281868
   PubMed Web of Science ®Google Scholar
• Centers for Disease Control and Prevention (CDC)Deaths from chronic obstructive pulmonary disease – United States, 2000–2005MMWR Morb Mortal Wkly Rep200857451229123219008792
   PubMedGoogle Scholar
• National Asthma Education and Prevention ProgramExpert Panel Report 3: Guidelines for the Diagnosis and Management of AsthmaNational Heart, Lung and Blood Institute2007 Available from: http://www.nhlbi.nih.gov/guidelines/asthmaAccessed October 5, 2011
   Google Scholar
• Global Initiative for AsthmaGlobal Strategy for Asthma Management and Prevention Updated 2010. Available from: http://www.ginaasthma.org/guidelines-global-strategy-for-diagnosis-management.htmlAccessed October 5, 2011
   Google Scholar
• Global Initiative for Chronic Obstructive Lung DiseaseGlobal Strategy for the Diagnosis, Management, and Prevention of Chronic Obstructive Pulmonary Disease Updated 2010. Available from: http://www.goldcopd.orgAccessed October 5, 2011
   Google Scholar
• Asthma in America: a landmark survey Available from: http://www.asthmainamerica.com/aaa_index.htmlAccessed October 5, 2011
   Google Scholar
• BlaissMSMeltzerEMurphyKRNathanRStoloffSWExecutive summary: asthma insight and management Available from: http://www.takingaimatasthma.com/pdf/executive-summary.pdfAccessed October 5, 2011
   Google Scholar
• HeffnerJEMularskiRACalverleyPMCOPD performance measures: missing opportunities for improving careChest201013751181118920348199
   PubMed Web of Science ®Google Scholar
• CampbellSMReevesDKontopantelisESibbaldBRolandMEffects of pay for performance on the quality of primary care in EnglandN Engl J Med2009361436837819625717
   PubMed Web of Science ®Google Scholar
• Van HerckPDe SmedtDAnnemansLRemmenRRosenthalMBSermeusWSystematic review: Effects, design choices, and context of pay-for-performance in health careBMC Health Serv Res20101024720731816
   PubMed Web of Science ®Google Scholar
• HerlandKAkselsenJPSkjønsbergOHBjermerLHow representative are clinical study patients with asthma or COPD for a larger “real life” population of patients with obstructive lung disease?Respir Med2005991111915672843
   PubMed Web of Science ®Google Scholar
• TraversJMarshSWilliamsMExternal validity of randomized controlled trials in asthma: to whom do the results of the trials apply?Thorax200762321922317105779
   PubMed Web of Science ®Google Scholar
• National Asthma Education and Prevention ProgramExpert Panel Report 2: Guidelines for the Diagnosis and Management of Asthma. National Heart, Lung and Blood Institute 1997 Available from: http://www.nhlbi.nih.gov/guidelines/asthmaAccessed October 5, 2011
   Google Scholar
• LegorretaAPChristian-HermanJO’ConnorRDHasanMMEvansRLeungKMCompliance with national asthma management guidelines and specialty careArch Intern Med199815854574649508223
   PubMedGoogle Scholar
• RastogiDShettyANeugebauerRHarijithANational Heart, Lung, and Blood Institute guidelines and asthma management practices among inner-city pediatric primary care providersChest2006129361962316537859
   PubMed Web of Science ®Google Scholar
• FuhlbriggeALAdamsRJGuilbertTWThe burden of asthma in the United States: level and distribution are dependent on interpretation of the national asthma education and prevention program guidelinesAm J Respir Crit Care Med200216681044104912379546
   PubMed Web of Science ®Google Scholar
• BacharierLBStrunkRCMaugerDWhiteDLemanskeRFJrSorknessCAClassifying asthma severity in children: mismatch between symptoms, medication use, and lung functionAm J Respir Crit Care Med2004170442643215172893
   PubMed Web of Science ®Google Scholar
• DoerschugKCPetersonMWDaytonCSKlineJNAsthma guidelines: an assessment of physician understanding and practiceAm J Respir Crit Care Med199915961735174110351911
   PubMed Web of Science ®Google Scholar
• BakerKMBrandDAHenJJrClassifying asthma: disagreement among specialistsChest200312462156216314665495
   PubMed Web of Science ®Google Scholar
• DietteGBKrishnanJAWolfendenLLSkinnerEASteinwachsDMWuAWRelationship of physician estimate of underlying asthma severity to asthma outcomesAnn Allergy Asthma Immunol200493654655215609763
   PubMed Web of Science ®Google Scholar
• WolfendenLLDietteGBKrishnanJASkinnerEASteinwachsDMWuAWLower physician estimate of underlying asthma severity leads to undertreatmentArch Intern Med2003163223123612546615
   PubMedGoogle Scholar
• VignolaAMChanezPCampbellAMAirway inflammation in mild intermittent and in persistent asthmaAm J Respir Crit Care Med199815724034099476850
   PubMed Web of Science ®Google Scholar
• Van den ToornLMOverbeekSEde JongsteJCLemanKHoogstedenHCPrinsJBAirway inflammation is present during clinical remission of atopic asthmaAm J Respir Crit Care Med2001164112107210311739143
   PubMed Web of Science ®Google Scholar
• FarahCSKermodeJADownieSRObesity is a determinant of asthma control independent of inflammation and lung mechanicsChest2011140365966621415135
   PubMed Web of Science ®Google Scholar
• ColiceGLBurgtJVSongJStamponePThompsonPJCategorizing asthma severityAm J Respir Crit Care Med199916061962196710588614
   PubMed Web of Science ®Google Scholar
• GreeningAPIndPWNorthfieldMShawGAdded salmeterol versus higher-dose corticosteroid in asthma patients with symptoms on existing inhaled corticosteroid. Allen and Hanburys Limited UK Study GroupLancet199434489172192247913155
   PubMed Web of Science ®Google Scholar
• ThomasMvon ZiegenweidtJLeeAJPriceDHigh-dose inhaled corticosteroids versus add-on long-acting β-agonists in asthma: an observational studyJ Allergy Clin Immunol2009123111612118986690
   PubMed Web of Science ®Google Scholar
• O’ByrnePMReddelHKColiceGLDoes the current stepwise approach to asthma pharmacotherapy encourage over-treatment?Respirology201015459660220384969
   PubMed Web of Science ®Google Scholar
• BatemanEDBousheyHABousquetJCan guideline-defined asthma control be achieved? The Gaining Optimal Asthma Control studyAm J Respir Crit Care Med2004170883684415256389
   PubMed Web of Science ®Google Scholar
• GreenRHBrightlingCEMcKennaSAsthma exacerbations and sputum eosinophil countsLancet200236093471715172112480423
   PubMed Web of Science ®Google Scholar
• SontJKWillemsLNBelEHvan KreikenJHVandenbrouckeJPSterkPJClinical control and histopathologic outcome of asthma when using airway hyperresponsiveness as an additional guide to long-term treatment. The AMPUL Study GroupAm J Respir Crit Care Med19991594 Pt 11043105110194144
   PubMed Web of Science ®Google Scholar
• SzeflerSJMitchellHSorknessCAManagement of asthma based on exhaled nitric oxide in addition to guideline-based treatment for inner-city adolescents and young adults: a randomized controlled trialLancet200837296431065107218805335
   PubMed Web of Science ®Google Scholar
• ShawDEBerryMAThomasMThe use of exhaled nitric oxide to guide asthma management: a randomized controlled trialAm J Respir Crit Care Med2007176323123717496226
   PubMed Web of Science ®Google Scholar
• SmithADCowanJOBrassettKPHerbisonGPTaylorDRUse of exhaled nitric oxide measurements to guide treatment in chronic asthmaN Engl J Med2005352212163217315914548
   PubMed Web of Science ®Google Scholar
• BergerWELegorretaAPBlaissMSThe utility of the Health Plan Employer Data and Information Set (HEDIS) asthma measure to predict asthma-related outcomesAnn Allergy Asthma Immunol200493653854515609762
   PubMed Web of Science ®Google Scholar
• CabanaMDSlishKKNanBClarkNMLimits of the HEDIS criteria in determining asthma severity for childrenPediatrics200411441049105515466104
   PubMed Web of Science ®Google Scholar
• GelfandEWColiceGLFromerLBunnWBIIIDaviesTJUse of the health plan employer data and information set for measuring and improving the quality of asthma careAnn Allergy Asthma Immunol200697329830517042134
   PubMed Web of Science ®Google Scholar
• ColiceGLYuAPIvanovaJICosts and resource use of mild persistent asthma patients initiated on controller therapyJ Asthma200845429329918446593
   PubMed Web of Science ®Google Scholar
• ColiceGWuEQBirnbaumHDaherMMarynchenkoMBVargheseSHealthcare and workloss costs associated with patients with persistent asthma in a privately insured populationJ Occup Environ Med200648879480216902372
   PubMed Web of Science ®Google Scholar
• BirnbaumHGIvanovaJIYuAPAsthma severity categorization using a claims-based algorithm or pulmonary function testingJ Asthma2009461677219191141
   PubMed Web of Science ®Google Scholar
• FuhlbriggeALCareyVJFinkelsteinJAValidity of the HEDIS criteria to identify children with persistent asthma and sustained high utilizationAm J Manag Care200511532533015898221
   PubMed Web of Science ®Google Scholar
• SchatzMZeigerRSImproving asthma outcomes in large populationsJ Allergy Clin Immunol2011128227327721497885
   PubMed Web of Science ®Google Scholar
• ParisJPetersonELWellsKRelationship between recent short-acting beta-agonist use and subsequent asthma exacerbationsAnn Allergy Asthma Immunol2008101548248719055201
   PubMed Web of Science ®Google Scholar
• SchatzMZeigerRSVollmerWMValidation of a beta-agonist long-term asthma control scale derived from computerized pharmacy dataJ Allergy Clin Immunol2006117115995100016675324
   PubMed Web of Science ®Google Scholar
• FDA News ReleaseOver-the-counter asthma inhalers containing chlorofluorocarbons (CFCs) will no longer be sold after December 31, 2011Targeted News Service9222011
   Google Scholar
• SchatzMZweigerRSVollmerWMThe controller-to-total asthma medication ratio is associated with patient-centered as well as utilization outcomesChest20061301435016840381
   PubMed Web of Science ®Google Scholar
• SchatzMNakahiroRCrawfordWMendozaGMosenDStiboltTBAsthma quality-of-care markers using administrative dataChest200512841968197316236843
   PubMed Web of Science ®Google Scholar
• YongPLWernerRMProcess quality measures and asthma exacerbations in the medicaid populationJ Allergy Clin Immunol2009124596196619748660
   PubMed Web of Science ®Google Scholar
• FirooziFLemièreCBeauchesneMFForgetABlaisLDevelopment and validation of database indexes of asthma severity and controlThorax200762758158717287299
   PubMed Web of Science ®Google Scholar
• GershonASWangCGuanJVasilevska-RistovskaJCicuttoLToTIdentifying patients with physician-diagnosed asthma in health administrative databasesCan Respir J200916618318820011725
   PubMed Web of Science ®Google Scholar
• BusseWWAsthma diagnosis and treatment: filling in the information gapsJ Allergy Clin Immunol2011128474075021875745
   PubMed Web of Science ®Google Scholar
• Ni ChroininMGreenstoneILassersonTJDucharmeFMAddition of long-acting beta2-agonists to inhaled steroids as first line therapy for persistent asthma in steroid-naïve adults and childrenCochrane Database Syst Rev20104CD00530719821344
   PubMedGoogle Scholar
• BlanchetteCCullerSDErshoffDGutierrezBAssociation between previous health care use and initiation of inhaled corticosteroid and long-acting beta2-adrenergic agonist combination therapy among US patients with asthmaClin Ther200931112574258320110003
   PubMed Web of Science ®Google Scholar
• YeXGutierrezBZarotskyVNelsonMBlanchetteCMAppropriate use of inhaled corticosteroid and long-acting beta2-adrenergic agonist combination therapy among asthma patients in a US commercially insured populationCurr Med Res Opin20092592251225819622006
   PubMed Web of Science ®Google Scholar
• FriedmanHWilcoxTReardonGCrespiSYawnBPA retrospective study of the use of fluticasone propionate/salmeterol combination therapy as initial asthma controller in a commercially insured populationClin Ther200830101908191719014847
   PubMed Web of Science ®Google Scholar
• ChowdhuryBADal PanGThe FDA and safe use of long-acting beta-agonists in the treatment of asthmaN Engl J Med2010362131169117120181964
   PubMed Web of Science ®Google Scholar
• BatemanENelsonHBousquetJMeta-analysis: effects of adding salmeterol to inhaled corticosteroids on serious asthma-related eventsAnn Intern Med20081491334218523132
   PubMed Web of Science ®Google Scholar
• SearsMROttossonARadnerFSuissaSLong-acting beta-agonists: a review of formoterol safety data from asthma clinical trialsEur Respir J2009331213218768573
   PubMed Web of Science ®Google Scholar
• WijesingheMWeatherallMPerrinKHarwoodMBeasleyRRisk of mortality associated with formoterol: a systematic review and meta-analysisEur Respir J200934480381119797669
   PubMed Web of Science ®Google Scholar
• PriceDMusgraveSDShepstoneLLeukotriene antagonists as first-line or add-on asthma-controller therapyN Engl J Med2011364181695170721542741
   PubMed Web of Science ®Google Scholar
• KaminskyDAMarcyTWBachandMIrvinCGKnowledge and use of office spirometry for the detection of chronic obstructive pulmonary disease by primary care physiciansRespir Care200550121639164816318645
   PubMedGoogle Scholar
• HardieJABuistASVollmerWMEllingsenIBakkePSMørkveORisk of over-diagnosis of COPD in asymptomatic elderly never-smokersEur Respir J20022051117112212449163
   PubMed Web of Science ®Google Scholar
• MillerMRHankinsonJBrusascoVStandardisation of spirometryEur Respir J200526231933816055882
   PubMed Web of Science ®Google Scholar
• PellegrinoRViegiGBrusascoVInterpretative strategies for lung function testsEur Respir J200526594896816264058
   PubMed Web of Science ®Google Scholar
• HankinsonJLOdencrantzJRFedanKBSpirometric reference values from a sample of the general US populationAm J Respir Crit Care19991591179187
   PubMed Web of Science ®Google Scholar
• StanojevicSWadeAStocksJReference ranges for spirometry across all ages: a new approachAm J Respir Crit Care Med2008177325326018006882
   PubMed Web of Science ®Google Scholar
• HankinsonJLKawutSMShaharESmithLJSutkovskyKHBarrRGPerformance of American Thoracic Society-recommended spirometry reference values in a multiethnic sample of adults: the multi-ethnic study of atherosclerosis (MESA) lung studyChest2010137113814519741060
   PubMed Web of Science ®Google Scholar
• SalviSSBarnesPJChronic obstructive pulmonary disease in nonsmokersLancet2009374969173374319716966
   PubMed Web of Science ®Google Scholar
• LamprechtBMcBurnieMAVollmerWMCOPD in never smokers: results from the population-based burden of obstructive lung disease studyChest2011139475276320884729
   PubMed Web of Science ®Google Scholar
• Van SickleDMagzamenSMullahyJUnderstanding socioeconomic and racial differences in adult lung functionAm J Respir Crit Care Med2011184552152721562132
   PubMed Web of Science ®Google Scholar
• WagnerPDFEV1 in the suburbs: choose your research subjects wiselyAm J Respir Crit Care Med2011184549549621885629
   PubMed Web of Science ®Google Scholar
• HerpelLBKannerRELeeSMVariability of spirometry in chronic obstructive pulmonary disease: results from two clinical trialsAm J Respir Crit Care Med2006173101106111316497996
   PubMed Web of Science ®Google Scholar
• GardnerZSRuppelGLKaminskyDAGrading the severity of obstruction in mixed obstructive-restrictive lung diseaseChest2011140359860321415132
   PubMed Web of Science ®Google Scholar
• AaronSDDalesRECardinalPHow accurate is spirometry at predicting restrictive pulmonary impairment?Chest1999115386987310084506
   PubMed Web of Science ®Google Scholar
• HyattRECowlCTBjorakerJAScanlonPDConditions associated with an abnormal nonspecific pattern of pulmonary function testsChest2009135241942418812444
   PubMed Web of Science ®Google Scholar
• IyerVNSchroederDRParkerKOHyattREScanlonPDThe nonspecific pulmonary function test: longitudinal follow-up and outcomesChest2011139487888620724741
   PubMed Web of Science ®Google Scholar
• JohannessenALehmannSOmenaasERPost-bronchodilator spirometry reference values in adults and implications for disease managementAm J Respir Crit Care Med2006173121316132516556696
   PubMed Web of Science ®Google Scholar
• JohannessenAOmenaasERBakkePSGulsvikAImplications of reversibility testing on prevalence and risk factors for chronic obstructive pulmonary disease: a community studyThorax2005601084284716085729
   PubMed Web of Science ®Google Scholar
• CalverleyPMBurgePSSpencerSAndersonJAJonesPWBronchodilator reversibility testing in chronic obstructive pulmonary diseaseThorax200358865966412885978
   PubMed Web of Science ®Google Scholar
• HanMKWiseRMumfordJPrevalence and clinical correlates of bronchoreversibility in severe emphysemaEur Resp J201035510481056
   Web of Science ®Google Scholar
• HananiaNACelliBRDonohueJFMartinUJBronchodilator reversibility in COPDChest201114041055106321972384
   PubMed Web of Science ®Google Scholar
• CulverBHObstructive? Restrictive? Or a ventilatory impairment?Chest2011140356856921896513
   PubMed Web of Science ®Google Scholar
• MillerMRQuanjerPHSwanneyMPRuppelGEnrightPLInterpreting lung function data using 80% predicted and fixed thresholds misclassifies more than 20% of patientsChest20111391525920522571
   PubMed Web of Science ®Google Scholar
• SchermerTRSmeeleIJThoonenBPCurrent clinical guideline definitions of airflow obstruction and COPD overdiagnosis in primary careEur Respir J200832494595218550607
   PubMed Web of Science ®Google Scholar
• RobbertsBSchermerTAbandoning FEV1/FVC <0.70 to detect airway obstructionChest201113951253125421540228
   PubMed Web of Science ®Google Scholar
• CelliBRHalbertRJPoint: should we abandon FEV1/FVC <0.70 to detect airway obstruction? NoChest201013851037104021051393
   PubMed Web of Science ®Google Scholar
• EnrightPBrusascoVCounterpoint: should we abandon FEV1/FVC < 0.70 to detect airway obstruction? YesChest201013851040104221051394
   PubMed Web of Science ®Google Scholar
• RabeKFWedzichaJAControversies in treatment of chronic obstructive pulmonary diseaseLancet201137897951038104721907867
   PubMed Web of Science ®Google Scholar
• AgustíAVestboJCurrent controversies and future perspectives in chronic obstructive pulmonary diseaseAm J Respir Crit Care Med2011184550751321680951
   PubMed Web of Science ®Google Scholar
• BuffelsJDegryseJHeyrmanJDecramerMDIDASCO StudyOffice spirometry significantly improves early detection of COPD in general practice: the DIDASCO studyChest200412541394139915078751
   PubMed Web of Science ®Google Scholar
• US Preventive Services Task ForceScreening for chronic obstructive pulmonary disease using spirometry: US Preventive Services Task Force recommendation statementAnn Intern Med2008148752953418316747
   PubMed Web of Science ®Google Scholar
• BroekhuizenBDSachsAPOostvogelsRHoesAWVerheijJMMoonsKGThe diagnostic value of history and physical examination for COPD in suspected or known cases: a systematic reviewFamily Pract2009264260268
   Web of Science ®Google Scholar
• PriceDBTinkelmanDGHalbertRJSymptom-based questionnaire for identifying COPD in smokersRespiration200673328529516330875
   PubMed Web of Science ®Google Scholar
• HurstJRVestboJAnzuetoASusceptibility to exacerbation in chronic obstructive pulmonary diseaseN Engl J Med2010363121128113820843247
   PubMed Web of Science ®Google Scholar
• GershonASWangCGuanJVasilevska-RistovskaJCicuttoLToTIdentifying individuals with physician diagnosed COPD in health administrative databasesCOPD20096538839419863368
   PubMedGoogle Scholar
• GershonASWarnerLCascagnettePVictorJCToTLifetime risk of developing chronic obstructive pulmonary disease: a longitudinal population studyLancet2011378979599199621907862
   PubMed Web of Science ®Google Scholar
• WuEQBirnbaumHGCifaldiMKangYMalletDColiceGDevelopment of a COPD severity scoreCurr Med Res Opin20062291679168716968571
   PubMed Web of Science ®Google Scholar
• EisnerMDTrupinLKatzPPDevelopment and validation of a survey-based COPD severity scoreChest200512761890189715947299
   PubMed Web of Science ®Google Scholar
• CalverleyPMAndersonJACelliBSalmeterol and fluticasone propionate and survival in chronic obstructive pulmonary diseaseN Engl J Med2007356877578917314337
   PubMed Web of Science ®Google Scholar
• TashkinDPCelliBSennSA 4-year trial of tiotropium in chronic obstructive pulmonary diseaseN Engl J Med2008359151543155418836213
   PubMed Web of Science ®Google Scholar
• KestenSJaraMWentworthCLanesSPooled clinical trial analysis of tiotropium safetyChest200613061695170317166984
   PubMed Web of Science ®Google Scholar
• LeeTAPickardASAuDHBartleBWeissKBRisk for death associated with medications for recently diagnosed chronic obstructive pulmonary diseaseAnn Intern Med2008149638039018794557
   PubMed Web of Science ®Google Scholar
• SinghSLokeYKFurbergCDInhaled anticholinergics and risk of major adverse cardiovascular events in patients with chronic obstructive pulmonary disease: a systematic review and meta-analysisJAMA2008300121439145018812535
   PubMed Web of Science ®Google Scholar
• MicheleTMPinheiroSIyasuSThe safety of tiotropium – the FDA’s conclusionsN Engl J Med2010363121097109920843240
   PubMed Web of Science ®Google Scholar
• SinghSLokeYKEnrightPLFurbergCDMortality associated with tiotropium mist inhaler in patients with chronic obstructive pulmonary disease: systematic review and meta-analysis of randomised controlled trialsBMJ2011342d321510.1136/bmj.d321521672999
   PubMed Web of Science ®Google Scholar
• BatemanESinghDSmithDEfficacy and safety of tiotropium Respimat SMI in COPD in two 1-year randomized studiesInt J Chron Obstruct Pulmon Dis2010519720820714373
   PubMedGoogle Scholar
• WedzichaJACalverleyPMSeemungalTAThe prevention of chronic obstructive pulmonary disease exacerbations by salmeterol/fluticasone propionate or tiotropium bromideAm J Respir Crit Care Med20081771192617916806
   PubMed Web of Science ®Google Scholar
• GershonACroxfordRToTComparison of inhaled long-acting β-agonist and anticholinergic effectiveness in older patients with chronic obstructive pulmonary disease: a cohort studyAnn Intern Med2011154958359221536937
   PubMed Web of Science ®Google Scholar
• RodrigoGJCastro-RodriguezJAPlazaVSafety and efficacy of combined long-acting beta–agonists and inhaled corticosteroids vs long-acting beta–agonists monotherapy for stable COPD: a systematic reviewChest200913641029103819633090
   PubMed Web of Science ®Google Scholar